AIDS care and treatment in sub-Saharan Africa: Implementation ethics

Hastings Center Report

Volumn 36, Issue 3, 2006, Pages 23-31

  Rennie, Stuart ^a   Behets, Frieda ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA SOUTH OF THE SAHARA; CONTROLLED CLINICAL TRIAL; ETHICS; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERNATIONAL COOPERATION; MASS SCREENING; NEEDS ASSESSMENT; PROGRAM DEVELOPMENT; RESEARCH ETHICS; REVIEW; UGANDA; UNITED STATES; WORLD HEALTH ORGANIZATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA SOUTH OF THE SAHARA; ANTI-HIV AGENTS; CONTROLLED CLINICAL TRIALS; ETHICS, RESEARCH; HEALTH CARE RATIONING; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; INTERNATIONAL COOPERATION; MASS SCREENING; MEDICALLY UNDERSERVED AREA; NEEDS ASSESSMENT; PROGRAM DEVELOPMENT; UGANDA; UNITED STATES; WORLD HEALTH ORGANIZATION; ZIDOVUDINE;

EID: 33745916442     PISSN: 00930334     EISSN: None     Source Type: Journal    
DOI: 10.1353/hcr.2006.0048     Document Type: Review

References (38)

1. M. Angell, "The Ethics of Clinical Research in the Developing World," New England Journal of Medicine 337 (1997): 847-49;
2. P. Lurie and S.M. Wolfe, "Unethical Trials of Interventions to Reduce Perinatal Transmission of the Human Immunodeficiency Virus in Developing Countries," New England Journal of Medicine 337 (1997): 853-56.
3. World Medical Association, "Declaration of Helsinki," at http://www.wma.net/ e/ethicsunit/helsinki.htm.
4. S. Benatar, "Commentary. Justice and Medical Research: A Global Perspective," Bioethics 15, no. 4 (2001): 333-40.
5. R.K. Lie et al., "The Standard of Care Debate: The Helsinki Declaration versus the International Consensus Opinion," Journal of Medical Ethics 30, no. 2 (2004): 190-93;
6. U. Schuklenk, "The Standard of Care Debate: Against the Myth of an 'International Consensus Opinion,'" Journal of Medical Ethics 30, no. 2 (2004): 194-97.
7. P. Farmer, Pathologies of Power: Health, Human Rights and the New War on the Poor (Berkeley, Calif.: University of California Press, 2003).
8. P. Farmer et al., "Community-Based Approaches to HIV-Treatment in Resource-Poor Settings," Lancet 358 (2001): 404-409.
9. E. Marseille et al., "HIV Prevention before HAART in Sub-Saharan Africa," Lancet 359 (2002): 1851-56.
10. W. Stevens et al., "Antiretroviral Therapy in Africa," British Medical Journal 328 (2004): 280-82.
11. V.H. Schmidt, "Models of Health Care Rationing," Current Sociology 52, no. 6 (2004): 969-88.
12. S. Rosen et al., "Rationing Antiretroviral Therapy for HIV/AIDS in Africa: Efficiency, Equity, and Reality," Health and Development Discussion Paper #4, Boston University, Center for International Health and Development; available at http:// www.bu.edu/dbin/sph/research_centers/ documents/HDDP4- rationingARTinAfrica.pdf〉 (February 2004).
13. WHO/UNAIDS, "'3 by 5' Country Profiles on Treatment Scale-Up," June 2005; available at http://www.who.int/ 3by5/countryprofiles/en/index1.html.
14. A. Jonsen, The Birth of Bioethics (Oxford, U.K.: Oxford University Press, 1998).
15. C. Olweny, "Bioethics in Developing Countries: Ethics of Scarcity and Sacrifice," Journal of Medical Ethics 20, no. 3 (1994): 169-74.
16. L. McGough et al., "Which Patients First? Setting Priorities for Antiretroviral Therapy Where Resources Are Limited," Presentation at 2004 International AIDS Conference, Bangkok, Thailand (Abstract WeOrb1277 in abstract program) (July 14, 2004).
17. See the detailed Web page on PEP-FAR at http://www.avert.org/pepfar.htm. Avert is an international HIV/AIDS charity organization based in the U.K.
18. B. Wilson, "Defense Contractors Seek $7 Billion Drug Contract," Morning Edition, National Public Radio, http:// www.npr.org/templates/story/story.php? storyId=4108743 (October 14, 2004);
19. USAID press release, "USAID Announces Contract to Swiftly Deliver Lifesaving Medicines and Supplies to Developing Countries," http://pepfar.pretoria.usembassy.gov/ wwwhmrusaidsept2705.html (September 27, 2005).
20. S. Heller, "Wealth Creation and Social Justice: An IMF Perspective," speaking notes prepared for the World Council of Churches, World Bank/IMF meeting, Geneva, February 13-14, 2003, http:// www.imf.org/external/np/speeches/ 2003/021303a.htm.
21. H. Burkhalter, "Misplaced Help in the AIDS Fight," The Washington Post, May 25, 2004;
22. D. Sanders et al., "Public Health in Africa," in Global Public Health: A New Era, ed. R. Beaglehole (Oxford, U.K.: Oxford University Press, 2003).
23. Action Aid International USA, "Blocking Progress: How the Fight against HIV/AIDS Is Being Undermined by the World Bank and the International Monetary Fund," September 2004, http://www. actionaidusa.org/ blockingprogress.php.
24. S. Rosen et al., "Rationing Antiretroviral Therapy," 12.
25. R. Macklin, "Ethics and Equity," 15; emphasis added.
26. Wilson and Blower (2005) offer a novel spatial mathematical model for dealing with the "where" question. Using South Africa as an example, they calculate where clinics dispensing ARVs should be placed given the numbers of people needing treatment, and how many drugs should be allocated to each clinic. D. Wilson and S. Blower, "Designing Equitable Antiretroviral Allocation Strategies in Resource-Constrained Countries," PLoS Medicine 2, no. 2 (2005): e50.
27. The study uses a thin conception of treatment equity as "equidistance to treatment," however, and it fails to factor in relevant nongeographic barriers to treatment access such as gender, income, presence of family support, workplace issues, and so on. For similar criticism see A. Capron and A. Reis, "Designing an Equitable Strategy for Allocating Antiretroviral Treatments," PLoS Medicine 2, no. 3 (2005): e69.
28. S. Rosen et al., "Hard Choices: Rationing Antiretroviral Therapy for HIV/AIDS in Africa," Lancet 365 (2005): 354-56.
29. N. Daniels, "How to Achieve Fair Distribution of ARTs in 3 by 5," background paper for the Consultation on Equitable Access to Treatment and Care for HIV/AIDS (January 26-27, 2004), WHO/UNAIDS; http://www.who.int/ ethics/en/ background-daniels3.pdf.
30. R. Cheek, "Playing God with HIV: Rationing HIV treatment in Southern Africa," African Security Review 10, no. 4 (2001).
31. WHO/Joint United Nations Program on HIV/AIDS, Consultation on Ethics and Equitable Access to Treatment and Care of HIV/AIDS, January 26-27, 2004; http://www.who.int/ethics/en/equity_art_ meeting_report_e.pdf.
32. A. Wasunna, "Human Ethical Issues Arising in ARV Scale-Up in Resource Constrained Settings," in Scaling Up Treatment for Global AIDS, ed. J. Curran (Washington, D.C.: The National Academies Press, 2004).
33. M. Nussbaum, Women and Human Development (Cambridge, U.K.: Cambridge University Press, 2000).
34. "Uganda Receives $37 Million in US AIDS Funding, Plans to Provide Antiretrovirals to Government Workers," Kaiser Daily HIV/AIDS Report, February 4, 2004; http://www.kaisernetwork.org/daily_reports/rep_index. cfm?hint=1&DR=22022.
35. N. Daniels, "How to Achieve," 16.
36. Personal communication.
37. L. Kapiriri et. al., "The Relationship between Prevention of Mother to Child Transmission of HIV and Stakeholder Decision-Making in Uganda: Implications for Health Policy," Health Policy 66 (2003): 199-211.
38. For a vision of this "sea change" and its underlying rationale, see S. Benatar, A. Daar, and P. Singer, "Global Health Ethics: The Rationale for Mutual Sharing," International Affairs 79, no. 1 (2003): 107-38.